CN106226426A - A kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer - Google Patents

A kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer Download PDF

Info

Publication number
CN106226426A
CN106226426A CN201610564044.6A CN201610564044A CN106226426A CN 106226426 A CN106226426 A CN 106226426A CN 201610564044 A CN201610564044 A CN 201610564044A CN 106226426 A CN106226426 A CN 106226426A
Authority
CN
China
Prior art keywords
membered ring
normal hexane
performance liquid
high performance
ring impurity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201610564044.6A
Other languages
Chinese (zh)
Other versions
CN106226426B (en
Inventor
杨汉跃
董淑波
王建涛
陈学民
郑家通
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JIANGSU DEYUAN PHARMACEUTICAL Co Ltd
Original Assignee
JIANGSU DEYUAN PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU DEYUAN PHARMACEUTICAL Co Ltd filed Critical JIANGSU DEYUAN PHARMACEUTICAL Co Ltd
Priority to CN201610564044.6A priority Critical patent/CN106226426B/en
Publication of CN106226426A publication Critical patent/CN106226426A/en
Application granted granted Critical
Publication of CN106226426B publication Critical patent/CN106226426B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of method that high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer: raw material five-membered ring impurity mixture of enantiomers is dissolved in organic solvent to concentration 0.1 ~ 25mg/ml;Use high performance liquid chromatograph, with Amylose-type chiral column as chromatographic column, carry out mutually splitting preparation for flowing with the mixed liquor that normal hexane forms with ethanol.The yield that the present invention splits preparation canagliflozin five-membered ring impurity enantiomer is high, and purity can reach more than 98%, is suitable as new drug development reference substance and uses.This method effectively achieves separation and the preparation of R, S configuration in five-membered ring impurity enantiomer, and its separating degree is up to more than 2.6.It is high that high performance liquid chromatography splits automaticity, and preparation efficiency is high.

Description

A kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer
Technical field
The present invention relates to the fractionation technology of chiral impurity in a kind of medicine, particularly a kind of high performance liquid chromatography splits card lattice The method arranging clean five-membered ring impurity enantiomer, belongs to pharmaceutical technology field.
Background technology
Canagliflozin (Canagliflozin) is the first SGLT2 inhibitor of FDA approval, is used for treating adult patients Type ii diabetes, be a kind of white 2(SGLT2 of new sodium glucose co-transporter 2) inhibitor medicaments, by suppression kidney pair The heavily absorption of glucose, increases glucose excretion, and then reduces the blood sugar level that diabetics has raised.
Owing to must strictly control by-product R, the S-configuration five-membered ring impurity of its building-up process generation in canagliflozin Content, R, S-configuration five-membered ring mixtures of impurities uses conventional method to be difficult to separate, it is impossible to it is carried out structure elucidation with accurate Quantitative study, therefore the liquid chromatograph method for splitting of a kind of R, S-configuration five-membered ring impurity of invention is particularly important.
R, S-configuration five-membered ring impurity structural formula is as follows:
Summary of the invention
It is an object of the invention to provide a kind of method that high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer.
The technical scheme that the present invention uses for achieving the above object is as follows: a kind of high performance liquid chromatography splits Ka Gelie The method of clean five-membered ring impurity enantiomer, is characterized in: raw material five-membered ring impurity mixture of enantiomers is dissolved in organic solvent extremely Concentration 0.1 ~ 25mg/ml;Use high performance liquid chromatograph, with Amylose-type chiral column as chromatographic column, with normal hexane and ethanol The mixed liquor of composition carries out for flowing splitting preparation mutually.
The method of institute of the present invention art guest's high performance liquid chromatography fractionation canagliflozin five-membered ring impurity enantiomer: described straight chain Starch type chiral column is preferably bonded chiral chromatographic column CHIRALPAK IE;Filler preferably Silica Surface is covalently bonded with directly Chain starch-three (3,5-Dichlorobenzene base carbamate).
One in the preferred dehydrated alcohol of organic solvent described in the inventive method, normal hexane, ethanol, methanol or several Plant the mixed solvent of composition.The mixture being particularly preferably made up of normal hexane and dehydrated alcohol, and the volume ratio of the two is, just Hexane: dehydrated alcohol=40 ~ 80: 60 ~ 20, further preferred normal hexane: dehydrated alcohol=60: 40.
In the inventive method, described flow rate of mobile phase is preferably 1.0 ~ 70mL/min, and chromatogram column temperature is preferably 25 ~ 40 DEG C, detection wavelength is preferably 220 ~ 290 nm.Described chromatogram column temperature more preferably 30 ~ 35 DEG C, detection wavelength is further It is preferably 220 ~ 254 nm.Described sample size is preferably 2 μ L ~ 10mL.
Flowing of the present invention mutually the most by volume percentage calculation, preferably normal hexane: dehydrated alcohol is 40 ~ 80: 60 ~ 20, most preferably normal hexane: dehydrated alcohol=60: 40.
In the inventive method, raw material five-membered ring impurity mixture of enantiomers be dissolved in organic solvent to concentration be preferably 5 ~ 20mg/ml。
Compared with prior art, the present invention have following technical effect that the present invention split preparation canagliflozin five-membered ring miscellaneous The yield of matter enantiomer is high, and purity can reach more than 98%, is suitable as new drug development reference substance and uses.The inventive method is effective Achieve R configuration, the separation of S configuration and preparation in five-membered ring impurity enantiomer, its separating degree is up to more than 2.6.High-efficient liquid Phase Chromatographic resolution automaticity is high, and preparation efficiency is high.
Accompanying drawing explanation
Fig. 1 is chromatographic isolation result figure in embodiment 6;
Fig. 2 is chromatographic isolation result figure in embodiment 7;
Fig. 3 and Fig. 4 is optical purity testing result figure in embodiment 8.
Detailed description of the invention
Below by being embodied as example and combining accompanying drawing the present invention is expanded on further, but it is not limiting as the present invention.
Embodiment 1, a kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer: by raw material five yuan Ring impurity mixture of enantiomers is dissolved in organic solvent to concentration 0.1mg/ml;Use high performance liquid chromatograph, with Amylose-type Chiral column is chromatographic column, carries out mutually splitting preparation with the mixed liquor that normal hexane forms with ethanol for flowing.Described amylose Type chiral column is bonded chiral chromatographic column CHIRALPAK IE.Described organic solvent is selected from dehydrated alcohol, normal hexane, second One in alcohol, methanol;Described flow rate of mobile phase is 1.0mL/min, and chromatogram column temperature is 25 DEG C, and detection wavelength is 220nm. Described sample size is 2 μ L.Flowing the most by volume percentage calculation, normal hexane: dehydrated alcohol is 40:60.
Embodiment 2, a kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer: by raw material five yuan Ring impurity mixture of enantiomers is dissolved in organic solvent to concentration 25mg/ml;Use high performance liquid chromatograph, with Amylose-type hands Property post be chromatographic column, the mixed liquor formed with ethanol with normal hexane carries out for flowing splitting preparation mutually.Described Amylose-type Chiral column is bonded chiral chromatographic column CHIRALPAK IE.Filler preferably Silica Surface is covalently bonded with amylose-three (3,5-Dichlorobenzene base carbamate).
The mixed solvent of the described organic solvent two kinds of compositions in dehydrated alcohol, normal hexane, ethanol, methanol.Institute The flow rate of mobile phase stated is 70mL/min, and chromatogram column temperature is 40 DEG C, and detection wavelength is 290 nm.Described sample size is 10mL.Flowing the most by volume percentage calculation, normal hexane: dehydrated alcohol is 80: 20,
Embodiment 3, a kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer: by miscellaneous for raw material five-membered ring Matter mixture of enantiomers is dissolved in organic solvent to concentration 5mg/ml;Use high performance liquid chromatograph, with Amylose-type chiral column For chromatographic column, carry out mutually splitting preparation with the mixed liquor that normal hexane forms with ethanol for flowing.Described Amylose-type chirality Post is bonded chiral chromatographic column CHIRALPAK IE.
The mixed solvent of the described organic solvent three kinds of compositions in dehydrated alcohol, normal hexane, ethanol, methanol.
Described flow rate of mobile phase is 10mL/min, and chromatogram column temperature is 30 DEG C, and detection wavelength is 280 nm.Described enters Sample amount is 1mL.Flowing the most by volume percentage calculation, normal hexane: dehydrated alcohol is 50: 50.
Embodiment 4, a kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer: by raw material five yuan Ring impurity mixture of enantiomers is dissolved in organic solvent to concentration 20mg/ml;Use high performance liquid chromatograph, with Amylose-type hands Property post be chromatographic column, the mixed liquor formed with ethanol with normal hexane carries out for flowing splitting preparation mutually.Described Amylose-type Chiral column is bonded chiral chromatographic column CHIRALPAK IE.
Described organic solvent is the mixture being made up of normal hexane and dehydrated alcohol, and the volume ratio of the two is, just own Alkane: dehydrated alcohol=60: 40.Described flow rate of mobile phase is 30mL/min, and chromatogram column temperature is 35 DEG C, and detection wavelength is 254nm.Described sample size is 5mL.Flowing the most by volume percentage calculation, normal hexane: dehydrated alcohol=60: 40.
Embodiment 5, a kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer: by raw material five yuan Ring impurity mixture of enantiomers is dissolved in organic solvent to concentration 1mg/ml;Use high performance liquid chromatograph, with Amylose-type hands Property post be chromatographic column, the mixed liquor formed with ethanol with normal hexane carries out for flowing splitting preparation mutually.Described Amylose-type Chiral column is bonded chiral chromatographic column CHIRALPAK IE.
Described organic solvent is the mixture being made up of normal hexane and dehydrated alcohol, and the volume ratio of the two is, just own Alkane: dehydrated alcohol=80: 20.Described flow rate of mobile phase is 5mL/min, and chromatogram column temperature is 32 DEG C, and detection wavelength is 254 nm.Described sample size is 5mL.Flowing the most by volume percentage calculation, normal hexane: dehydrated alcohol=60: 40.
Embodiment 6, the methods experiment one of a kind of high performance liquid chromatography fractionation canagliflozin five-membered ring impurity enantiomer:
By five-membered ring impurity mixture of enantiomers 1 ~ 2ml chromatographic grade anhydrous alcohol solution, use analytical type high performance liquid chromatography Instrument carries out isolated and purified, and column size is 0.46 cm I.D. × 15 cm L, and Silica Surface is covalently bonded with straight chain and forms sediment Powder-three (3,5-Dichlorobenzene base carbamate) filler is Daicel medicine chiral technology (Shanghai) Co., Ltd. product, particle diameter Being 5 μm, sample introduction 2 μ l, chromatogram column temperature is 35 DEG C, and flowing is normal hexane/dehydrated alcohol (60/40, V/V) mutually, isocratic elution 1ml/min, elution time 8min.The detection wavelength of the New UV Spectrophotometric detector used is 254nm.
Chromatographic isolation result as shown in Figure 1, from Fig. 1 it can be seen that R-configuration five-membered ring impurity chromatographic peak is when retaining Between be the five-membered ring impurity chromatographic peak retention time of 5.043min, S-configuration be 6.099min, R-configuration and five yuan of S-configuration Both ring impurity separating degree is 2.637.
Embodiment 7, the methods experiment two of a kind of high performance liquid chromatography fractionation canagliflozin five-membered ring impurity enantiomer:
By five-membered ring impurity mixture of enantiomers 1 ~ 2ml chromatographic grade anhydrous alcohol solution, use analytical type high performance liquid chromatography Instrument carries out isolated and purified, and column size is 0.46 cm I.D. × 25 cm L, and Silica Surface is covalently bonded with straight chain and forms sediment Powder-three (3,5-Dichlorobenzene base carbamate) filler is Daicel medicine chiral technology (Shanghai) Co., Ltd. product, particle diameter Being 5 μm, sample introduction 30 μ l, chromatogram column temperature is 35 DEG C, and flowing is normal hexane/dehydrated alcohol (60/40, V/V) mutually, isocratic elution 1ml/min, elution time 20min.The detection wavelength of the New UV Spectrophotometric detector used is 254nm, R-configuration five-membered ring impurity Chromatographic peak retention time is 10.864 min, and the five-membered ring impurity chromatographic peak retention time of S-configuration is 11.974min, R-structure The five-membered ring impurity separating degree of type and S-configuration is 2.391.
Chromatographic isolation result as shown in Figure 2, from figure 2 it can be seen that R-configuration five-membered ring impurity chromatographic peak retention time Five-membered ring impurity chromatographic peak retention time for 10.864min, S-configuration is 11.974min, R-configuration and five yuan of S-configuration Both ring impurity separating degree is 2.391.
Embodiment 8, the methods experiment three of a kind of high performance liquid chromatography fractionation canagliflozin five-membered ring impurity enantiomer:
By five-membered ring impurity mixture of enantiomers 10ml chromatographic grade anhydrous alcohol solution, use preparative high performance liquid chromatography instrument Carrying out isolated and purified, column size is 5.0 cm I.D. × 25 cm L, and Silica Surface is covalently bonded with amylose-three (3,5-Dichlorobenzene base carbamate) filler is Daicel medicine chiral technology (Shanghai) Co., Ltd. product, applied sample amount 231.9mg, sample introduction 10ml, chromatogram column temperature is 35 DEG C, and flowing is normal hexane/dehydrated alcohol (60/40, V/V) mutually, isocratic elution 60ml/min, elution time 8min.The detection wavelength of New UV Spectrophotometric detector used is 254nm, collect respectively R-configuration and The five-membered ring impurity of S-configuration.Collection liquid 40 DEG C is concentrated to dryness.
Optical purity testing result is as shown in Fig. 3 ~ 4, from figure 3, it can be seen that R-configuration five-membered ring impurity ee% is 99.90%.Figure 4, it is seen that the five-membered ring impurity ee% of S-configuration is 98.68%.
R-configuration five-membered ring impurity yield: 0.1330g(57.4%), S-configuration five-membered ring impurity yield: 0.0940g (40.5%), total recovery is 97.9%.
R-configuration five-membered ring impurity HRMS:[M+Na]+= 467.13190;MS:[M+Na]+=467
R-configuration five-membered ring impurity1H-NMR(CDCl3,400M): δ=7.59 (dd, 2H);7.27 (d, 1H);7.26 (s, 1H); 7.21 (d, 1H);7.19 (t, 2H);7.11 (d, 1H);6.79 (d, 1H);5.35(s,1H);4.85 (s, 1H);4.60 (s, 1H); 4.46 (d, 3H);4.41 (s, 1H);4.11 (s, 2H);4.00 (s, 1H);3.85 (m, 1H);3.82 (m, 1H);3.81 (m, 1H);3.64 (d, 1H);3.44 (dd, 1H);2.26 (s, 3H).
In sum, the high performance liquid chromatography of a kind of canagliflozin five-membered ring impurity enantiomer of the present invention splits, prepares Method, effectively can well separate the five-membered ring impurity of R-configuration and S-configuration, and reach quickly to prepare.
The above is only the citing of embodiments of the present invention, it is noted that for the ordinary skill of the art For personnel, on the premise of without departing from the technology of the present invention principle, it is also possible to make some improvement and modification, these improve and become Type also should be regarded as protection scope of the present invention.

Claims (10)

1. the method that a high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer, it is characterised in that: by raw material five Ring impurity mixture of enantiomers is dissolved in organic solvent to concentration 0.1 ~ 25mg/ml;Use high performance liquid chromatograph, form sediment with straight chain Powder type chiral column is chromatographic column, carries out mutually splitting preparation with the mixed liquor that normal hexane forms with ethanol for flowing.
Method the most according to claim 1, it is characterised in that: described Amylose-type chiral column is bonded chiral Chromatographic column CHIRALPAK IE;Filler preferably Silica Surface is covalently bonded with amylose-three (3,5-Dichlorobenzene base amino first Acid esters).
Method the most according to claim 1, it is characterised in that: described organic solvent is selected from dehydrated alcohol, normal hexane, second The mixed solvent of one or several compositions in alcohol, methanol.
Method the most according to claim 3, it is characterised in that: described organic solvent is by normal hexane and dehydrated alcohol The mixture of composition, and the volume ratio of the two is, normal hexane: dehydrated alcohol=40 ~ 80: 60 ~ 20.
Method the most according to claim 4, it is characterised in that: normal hexane: dehydrated alcohol=60: 40.
Method the most according to claim 1, it is characterised in that: described flow rate of mobile phase is 1.0 ~ 70mL/min, chromatograph Column temperature is 25 ~ 40 DEG C, and detection wavelength is 220 ~ 290 nm.
Method the most according to claim 6, it is characterised in that: described chromatogram column temperature is 30 ~ 35 DEG C, and detection wavelength is 220~254 nm。
Method the most according to claim 1, it is characterised in that: described sample size is 2 μ L ~ 10mL.
Method the most according to claim 1, it is characterised in that: flowing the most by volume percentage calculation, normal hexane: anhydrous Ethanol is 40 ~ 80: 60 ~ 20, preferably normal hexane: dehydrated alcohol=60: 40.
Method the most according to claim 1, it is characterised in that: raw material five-membered ring impurity mixture of enantiomers is dissolved in organic Solvent is to concentration 5 ~ 20mg/ml.
CN201610564044.6A 2016-07-18 2016-07-18 A kind of method that high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer Active CN106226426B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610564044.6A CN106226426B (en) 2016-07-18 2016-07-18 A kind of method that high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610564044.6A CN106226426B (en) 2016-07-18 2016-07-18 A kind of method that high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer

Publications (2)

Publication Number Publication Date
CN106226426A true CN106226426A (en) 2016-12-14
CN106226426B CN106226426B (en) 2019-03-08

Family

ID=57519638

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610564044.6A Active CN106226426B (en) 2016-07-18 2016-07-18 A kind of method that high performance liquid chromatography splits canagliflozin five-membered ring impurity enantiomer

Country Status (1)

Country Link
CN (1) CN106226426B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109374783A (en) * 2018-12-21 2019-02-22 安徽联创生物医药股份有限公司 A method of with the related substance of HPLC separation determination canagliflozin bulk pharmaceutical chemicals
CN109528710A (en) * 2018-12-19 2019-03-29 黄泳华 Composition containing tolylthiophene class compound
CN111077234A (en) * 2018-10-19 2020-04-28 重庆医药工业研究院有限责任公司 Method for separating and determining canagliflozin and impurities thereof by using liquid chromatography
CN111514612A (en) * 2020-04-29 2020-08-11 江苏德源药业股份有限公司 Method for rapidly splitting pioglitazone hydrochloride racemate by supercritical fluid chromatography

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070207A1 (en) * 2004-01-16 2005-08-04 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
WO2010042674A1 (en) * 2008-10-08 2010-04-15 Bristol-Myers Squibb Company Pyrrolone melanin concentrating hormone receptor-1 antagonists
WO2012125622A1 (en) * 2011-03-14 2012-09-20 Bristol-Myers Squibb Company Substituted adipic acid amides and uses thereof
CN105319294A (en) * 2014-06-20 2016-02-10 重庆医药工业研究院有限责任公司 Method for separating and testing canagliflozin and matter related to same
CN105548378A (en) * 2015-12-03 2016-05-04 上海应用技术学院 Method for separation of Canagliflozin alpha and beta isomers

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070207A1 (en) * 2004-01-16 2005-08-04 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
WO2010042674A1 (en) * 2008-10-08 2010-04-15 Bristol-Myers Squibb Company Pyrrolone melanin concentrating hormone receptor-1 antagonists
WO2012125622A1 (en) * 2011-03-14 2012-09-20 Bristol-Myers Squibb Company Substituted adipic acid amides and uses thereof
CN105319294A (en) * 2014-06-20 2016-02-10 重庆医药工业研究院有限责任公司 Method for separating and testing canagliflozin and matter related to same
CN105548378A (en) * 2015-12-03 2016-05-04 上海应用技术学院 Method for separation of Canagliflozin alpha and beta isomers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MUZAFFAR IQBAL 等: "A simple and sensitive high performance liquid chromatography assay with a fluorescence detector for determination of canagliflozin in human plasma", 《ANAL. METHODS》 *
UTTAM PRASAD PANIGRAHY 等: "A Novel Validated RP-HPLC-DAD Method for the Simultaneous Estimation of Metformin Hydrochloride and Canagliflozin in Bulk and Pharmaceutical Tablet Dosage form with Forced Degradation Studies", 《ORIENTAL JOURNAL OF CHEMISTRY》 *
宋波 等: "一种坎格列净工艺杂质的制备分离与结构鉴定", 《中国医药工业杂志》 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111077234A (en) * 2018-10-19 2020-04-28 重庆医药工业研究院有限责任公司 Method for separating and determining canagliflozin and impurities thereof by using liquid chromatography
CN111077234B (en) * 2018-10-19 2023-09-15 重庆医药工业研究院有限责任公司 Method for separating and measuring canagliflozin and impurities thereof by liquid chromatography
CN109528710A (en) * 2018-12-19 2019-03-29 黄泳华 Composition containing tolylthiophene class compound
CN109374783A (en) * 2018-12-21 2019-02-22 安徽联创生物医药股份有限公司 A method of with the related substance of HPLC separation determination canagliflozin bulk pharmaceutical chemicals
CN109374783B (en) * 2018-12-21 2022-02-01 安徽联创生物医药股份有限公司 Method for separating and determining related substances of canagliflozin bulk drug by using HPLC (high performance liquid chromatography)
CN111514612A (en) * 2020-04-29 2020-08-11 江苏德源药业股份有限公司 Method for rapidly splitting pioglitazone hydrochloride racemate by supercritical fluid chromatography

Also Published As

Publication number Publication date
CN106226426B (en) 2019-03-08

Similar Documents

Publication Publication Date Title
CN105154478B (en) A kind of method of high speed adverse current chromatogram and high performance liquid chromatography combination preparation high-purity hydroxytyrosol
CN106226426A (en) A kind of high performance liquid chromatography splits the method for canagliflozin five-membered ring impurity enantiomer
CN106706768B (en) Method for separating and measuring empagliflozin and related substances thereof
CN106967137B (en) Method for separating high-purity oleuropein by liquid chromatography through macroporous resin combined preparation
CN101987815B (en) Purification process for preparing high-purity coenzyme Q10
CN109406679A (en) A kind of detection method of high effective liquid chromatography for measuring agalloch eaglewood quality
CN106226427A (en) A kind of supercritical fluid chromatography quickly splits the method for aranidipine racemic modification
CN101230080B (en) simulated moving bed chromatography separation of 20(S) and 20(R)-ginsenoside Rg3 enantiomer
CN114988979B (en) Method for preparing high-purity lycopene by macro separation
CN109406685B (en) High performance liquid chromatography method for separating carfilzomib and isomers thereof
CN110746302B (en) Method for separating and preparing phenolic acid compounds in echinacea purpurea
Bhushan et al. HPLC resolution of thioridazine enantiomers from pharmaceutical dosage form using cyclodextrin-based chiral stationary phase
Liu et al. A simple and efficient method for the extraction and purification of tuberostemonine from Stemonae Radix using an amide group-based monolithic cartridge
CN109651170A (en) A kind of method of high speed adverse current chromatogram separation sertraline hydrochloride cis-trans-isomer
CN110501200B (en) Method for extracting and separating effective components of recyclable black nightshade
CN105738533B (en) method for separating and measuring 1, 2-propylene glycol enantiomer by gas chromatography
CN108794299A (en) The method of purified solanesol
CN107064336A (en) A kind of method of pre-column derivatization Analyze & separate Ke Linei esterdiol enantiomters
CN106831943A (en) A kind of method of low cost purifying transdermal peptide
CN102389456A (en) Method for extracting isodon japonica var.galaucocalyx total diterpenoids or Glaucocalyxin A
CN102093210A (en) Purified preparation method of six ginkgoic acid monomers
CN100434135C (en) Method for separating and purifying natural product using three-phase counter current chromatograph
CN112047988B (en) Paederoside monomer compound, preparation method and application thereof
CN110066256B (en) Purification method of 5-chloro-2-methyl-4-isothiazolin-3-one
CN108685968A (en) A kind of purification process of Italy's oxtongue general flavone

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant